The weekly litigation news digest is live. Subscribe now

IP Verse

Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist - EP3470432

The patent EP3470432 was granted to Regeneron Pharmaceuticals on Oct 6, 2021. The application was filed on Aug 20, 2013 under application number EP18194745A. The patent is currently recorded with a legal status of "Revoked".

EP3470432

REGENERON PHARMACEUTICALS
Application Number
EP18194745A
Filing Date
Aug 20, 2013
Status
Revoked
May 19, 2023
Publication Date
Oct 6, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
D YOUNGJul 6, 2022D YOUNGADMISSIBLE
NEUEFEINDJul 6, 2022MAIWALDADMISSIBLE
DR H ULRICH DORRIESJul 5, 2022DORRIESADMISSIBLE
DR H ULRICH DORRIESJul 5, 2022DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMANADMISSIBLE
SECERNAJul 5, 2022-ADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2012097565
DESCRIPTIONUS6596541
DESCRIPTIONUS6927044
DESCRIPTIONUS7582298
DESCRIPTIONUS7608693
DESCRIPTIONUS8178098
OPPOSITIONUS8075887
OPPOSITIONWO2010053751
OPPOSITIONWO2014031610
SEARCHWO2010053751

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents